Search Results - "Bellamy, C O C"

Refine Results
  1. 1

    Functional Immune Anatomy of the Liver—As an Allograft by Demetris, A. J., Bellamy, C. O. C., Gandhi, C. R., Prost, S., Nakanuma, Y., Stolz, D. B.

    Published in American journal of transplantation (01-06-2016)
    “…The liver is an immunoregulatory organ in which a tolerogenic microenvironment mitigates the relative “strength” of local immune responses. Paradoxically,…”
    Get full text
    Journal Article
  2. 2

    Working with Commercially Available Quantum Dots for Immunofluorescence on Tissue Sections by Prost, Sandrine, Kishen, Ria E B, Kluth, David C, Bellamy, Christopher O C

    Published in PloS one (29-09-2016)
    “…Quantum dots are semiconductor fluorescent nanocrystals that exhibit excellent characteristics compared with more commonly used organic fluorescent dyes. For…”
    Get full text
    Journal Article
  3. 3

    Banff Fibrosis Study: Multicenter Visual Assessment and Computerized Analysis of Interstitial Fibrosis in Kidney Biopsies by Farris, A. B., Chan, S., Climenhaga, J., Adam, B., Bellamy, C. O. C., Serón, D., Colvin, R. B., Reeve, J., Mengel, M.

    Published in American journal of transplantation (01-04-2014)
    “…Increasing interstitial fibrosis (IF) in native and kidney transplant biopsies is associated with functional decline and serves as a clinical trial end point…”
    Get full text
    Journal Article
  4. 4

    Choice of Illumination System & Fluorophore for Multiplex Immunofluorescence on FFPE Tissue Sections by Prost, Sandrine, Kishen, Ria E B, Kluth, David C, Bellamy, Christopher O C

    Published in PloS one (15-09-2016)
    “…The recent availability of novel dyes and alternative light sources to facilitate complex tissue immunofluorescence studies such as multiplex labelling has not…”
    Get full text
    Journal Article
  5. 5

    A case of membranous nephropathy with microspherular deposits progressing to collapsing nephropathy and dialysis dependency, but with full recovery following immunosuppression by Sayer, Matthew, Pattle, Samuel, Phelan, Paul J, Bellamy, Christopher O C

    Published in Clinical nephrology (01-04-2023)
    “…Membranous nephropathy with microspherular deposits is a rare renal condition associated with sub-nephrotic or nephrotic-range proteinuria. We report a case…”
    Get more information
    Journal Article
  6. 6

    Activation of thiazide-sensitive co-transport by angiotensin II in the cyp1a1-Ren2 hypertensive rat by Ashek, Ali, Menzies, Robert I, Mullins, Linda J, Bellamy, Christopher O C, Harmar, Anthony J, Kenyon, Christopher J, Flatman, Peter W, Mullins, John J, Bailey, Matthew A

    Published in PloS one (27-04-2012)
    “…Transgenic rats with inducible expression of the mouse Ren2 gene were used to elucidate mechanisms leading to the development of hypertension and renal injury…”
    Get full text
    Journal Article
  7. 7
  8. 8

    C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status by Bellamy, C O C, Herriot, M M, Harrison, D J, Bathgate, A J

    Published in Histopathology (01-05-2007)
    “…Aims:  To determine whether C4d immunopositivity helps recognition of humoral rejection in dysfunctional liver allografts. Methods and results:  C4d…”
    Get full text
    Journal Article
  9. 9

    Detection of viral hepatitis E in clinical liver biopsies by Prost, Sandrine, Crossan, Claire L, Dalton, Harry R, De Man, Robert A, Kamar, Nassim, Selves, Janick, Dhaliwal, Catharine, Scobie, Linda, Bellamy, Christopher O C

    Published in Histopathology (01-10-2017)
    “…Aims To determine the relative utility of in‐situ testing for hepatitis E virus (HEV) RNA and paraffin‐section polymerase chain reaction (PCR) to diagnose HEV…”
    Get full text
    Journal Article
  10. 10

    Acute Liver Injury Is Independent of B Cells or Immunoglobulin M by Richards, James A, Bucsaiova, Martina, Hesketh, Emily E, Ventre, Chiara, Henderson, Neil C, Simpson, Kenneth, Bellamy, Christopher O C, Howie, Sarah E M, Anderton, Stephen M, Hughes, Jeremy, Wigmore, Stephen J

    Published in PloS one (25-09-2015)
    “…Acute liver injury is a clinically important pathology and results in the release of Danger Associated Molecular Patterns, which initiate an immune response…”
    Get full text
    Journal Article
  11. 11

    Additive effect of p53, p21 and Rb deletion in triple knockout primary hepatocytes by SHEAHAN, Sharon, BELLAMY, Christopher O. C, TREANOR, Louise, HARRISON, David J, PROST, Sandrine

    Published in Oncogene (26-02-2004)
    “…Using Cre-Lox technology to inducibly delete Rb from wild-type, p21- and/or p53-deficient primary hepatocytes, we investigated the role of p53, p21 and pRb in…”
    Get full text
    Journal Article
  12. 12

    The value of immunophenotyping hepatocellular adenomas: consecutive resections at one UK centre by Bellamy, Christopher O C, Maxwell, R Scott, Prost, Sandrine, Azodo, Ijeoma A, Powell, James J, Manning, Jonathan R

    Published in Histopathology (01-02-2013)
    “…Aims:  To determine the utility of immunophenotyping for classification of hepatocellular adenomas resected at one Scottish centre. Methods and results:  This…”
    Get full text
    Journal Article
  13. 13

    Letrozole as primary medical therapy for locally advanced and large operable breast cancer by DIXON, J. M, LOVE, C. D. B, BELLAMY, C. O. C, CAMERON, D. A, LEONARD, R. C. F, SMITH, H, MILLER, W. R

    Published in Breast cancer research and treatment (01-04-2001)
    “…To investigate the efficacy of letrozole 2.5 mg and 10 mg used as primary neoadjuvant therapy for patients with locally advanced and large operable breast…”
    Get full text
    Journal Article
  14. 14

    p53 and apoptosis by BELLAMY, C. O. C

    Published in British medical bulletin (1997)
    “…Loss of fuction of the p53 tumour suppressor gene is a frequent and important event in the genesis or progession of many human malignancies. Loss of p53…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Angiotensin-converting Enzyme Is a Modifier of Hypertensive End Organ Damage by Liu, Xiaojun, Bellamy, Christopher O.C., Bailey, Matthew A., Mullins, Linda J., Dunbar, Donald R., Kenyon, Christopher J., Brooker, Gillian, Kantachuvesiri, Surasak, Maratou, Klio, Ashek, Ali, Clark, Allan F., Fleming, Stewart, Mullins, John J.

    Published in The Journal of biological chemistry (05-06-2009)
    “…Severe forms of hypertension are characterized by high blood pressure combined with end organ damage. Through the development and refinement of a transgenic…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Endothelin Receptor Antagonism and Renin Inhibition as Treatment Options for Scleroderma Kidney by Dhaun, Neeraj, MBChB, MacIntyre, Iain M., MBChB, Bellamy, Christopher O.C., PhD, MBBS, FRCPath, Kluth, David C., PhD, MBBS

    Published in American journal of kidney diseases (01-10-2009)
    “…Scleroderma renal crisis (SRC) is an important complication of scleroderma associated with significant morbidity and mortality. Current treatment of patients…”
    Get full text
    Journal Article
  19. 19
  20. 20

    A Switch in the Mechanism of Hypertension in the Syndrome of Apparent Mineralocorticoid Excess by BAILEY, Matthew A, PATERSON, Janice M, HADOKE, Patrick W. F, WROBEL, Nicola, BELLAMY, Christopher O. C, BROWNSTEIN, David G, SECKL, Jonathan R, MULLINS, John J

    “…The syndrome of apparent mineralocorticoid excess arises from nonfunctional mutations in 11beta-hydroxysteroid dehydrogenase type 2 (11betaHSD2), an enzyme…”
    Get full text
    Journal Article